TY - JOUR
T1 - A point of view
T2 - Quantitative and qualitative imbalance in disease pathogenesis; pulmonary surfactant protein A genetic variants as a model
AU - Floros, Joanna
AU - Wang, Guirong
N1 - Funding Information:
The authors thank Sue Myers for typing this paper. Supported by NIH R37 HL34788 and NIEHS R01-ES-09882.
PY - 2001/5
Y1 - 2001/5
N2 - The high degree of similarity at the molecular level, between humans and other species, has provided the rationale for the use of a variety of species as model systems in research, resulting in enormous advances in biological sciences and medicine. In contrast, the individual variability observed among humans, for example, in external physique, organ functionality and others, is accounted for, by only a fraction of 1% of differences at the DNA level. These small differences, which are essential for understanding disease pathogenesis, have posed enormous challenges in medicine, as we try to understand why patients may respond differently to drugs or why one patient has complications and another does not. Differences in outcome are most likely the result of interactions among genetic components themselves and/or the environment at the molecular, cellular, organ, or organismal level, or the macroenvironment. In this paper: (1) we consider some issues for multifactorial disease pathogenesis; (2) we provide a review of human SP-A and how the knowledge gained and the characteristics of the hSP-A system may serve as a model in the study of disease with multifactorial etiology; and (3) we describe examples where hSP-A has been used in the study of disease.
AB - The high degree of similarity at the molecular level, between humans and other species, has provided the rationale for the use of a variety of species as model systems in research, resulting in enormous advances in biological sciences and medicine. In contrast, the individual variability observed among humans, for example, in external physique, organ functionality and others, is accounted for, by only a fraction of 1% of differences at the DNA level. These small differences, which are essential for understanding disease pathogenesis, have posed enormous challenges in medicine, as we try to understand why patients may respond differently to drugs or why one patient has complications and another does not. Differences in outcome are most likely the result of interactions among genetic components themselves and/or the environment at the molecular, cellular, organ, or organismal level, or the macroenvironment. In this paper: (1) we consider some issues for multifactorial disease pathogenesis; (2) we provide a review of human SP-A and how the knowledge gained and the characteristics of the hSP-A system may serve as a model in the study of disease with multifactorial etiology; and (3) we describe examples where hSP-A has been used in the study of disease.
UR - http://www.scopus.com/inward/record.url?scp=0035012240&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035012240&partnerID=8YFLogxK
U2 - 10.1016/S1095-6433(01)00325-7
DO - 10.1016/S1095-6433(01)00325-7
M3 - Article
C2 - 11369553
AN - SCOPUS:0035012240
SN - 1095-6433
VL - 129
SP - 295
EP - 303
JO - Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology
JF - Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology
IS - 1
ER -